co-produced by:

AI, ML, & LLM: Revolutionizing Therapeutic Development

Wednesday, January 15, 2025 | 2:30–3:30PM 
Hilton San Francisco Union Square
Imperial Ballroom

PANEL SESSION OPEN TO THE PUBLIC

Disclaimer. The organizers of Biotech Showcase may make changes to the speaker lineup and topics to be discussed during the session. Please check this page for the latest updates.

Moderated by:

Maria Luisa Pineda
Co-Founder & CEO, 
Envisagenics 

Panelists:

Andrei Georgescu
CEO & Co-Founder,
Vivodyne

Wyatt McDonnell
CEO & Founding Scientist,
Infinimmune

Khai Minh Pham
Founder & CEO,
ThinkingNodeLife.ai

Hannah Wastyk
Co-Founder & CEO,
Interface Biosciences

More about the session

Large language models (LLMs) and artificial intelligence (AI) are transforming the pharmaceutical industry by streamlining processes across the entire drug development lifecycle. These technologies enable researchers to generate hypotheses, extract insights from vast datasets, detect patterns, and simplify literature searches through natural language interactions. Beyond drug discovery, AI has the potential to revolutionize various aspects of therapeutic development, including research, clinical trials, regulatory filings, and manufacturing.

Kfir Schreiber
CO-founder & CEO,
DeepCure

Panel Summary 

SESSION OPEN TO THE PUBLIC

Complete the form below to submit your RSVP for this free session during Biotech Showcase